Blau Farmacêutica Income Statement

Financials in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,769	1,754	1,373	1,407	1,366	1,182
Revenue Growth (YoY)	4.94%	27.81%	-2.44%	2.96%	15.62%	20.90%
Cost of Revenue	1,057	1,096	882.38	739.03	700.47	625.84
Gross Profit	711.69	658.75	490.25	667.88	665.93	555.97
Selling, General & Admin	329.91	303.77	150.28	213.85	201.77	161.36
Other Operating Expenses	-35.44	1.5	-117.75	1.83	5.41	4.93
Operating Expenses	293.41	319.95	41.97	215.69	209.31	166.83
Operating Income	418.28	338.8	448.28	452.19	456.62	389.13
Interest Expense	-59.2	-58.31	-32.11	-32.43	-26.8	-15.32
Interest & Investment Income	52.55	46.69	55.8	70.22	34.95	5.23
Earnings From Equity Investments	-	-	0.16	-	-	-
Currency Exchange Gain (Loss)	-2.46	-18.89	-8.6	-4.45	1.23	-24.77
Other Non Operating Income (Expenses)	36.78	-6.39	-10.3	-16.97	16.46	-0.63
EBT Excluding Unusual Items	445.95	301.89	453.23	468.56	482.47	353.64
Other Unusual Items	-10	-10	-119	-	-	-
Pretax Income	435.95	291.89	334.23	468.56	482.47	353.64
Income Tax Expense	119.54	78.36	86.74	108.07	158.6	99.31
Earnings From Continuing Operations	316.42	213.53	247.49	360.49	323.86	254.33
Minority Interest in Earnings	0.13	3.68	2.32	2.88	1.36	-
Net Income	316.54	217.21	249.81	363.37	325.22	254.33
Net Income to Common	324.56	217.21	249.81	363.37	325.22	254.33
Net Income Growth	69.23%	-13.05%	-31.25%	11.73%	27.87%	27.01%
Shares Outstanding (Basic)	232	231	231	231	233	192
Shares Outstanding (Diluted)	232	231	231	231	233	205
Shares Change (YoY)	0.52%	-	-0.08%	-0.87%	13.84%	4.39%
EPS (Basic)	1.40	0.94	1.08	1.57	1.39	1.32
EPS (Diluted)	1.40	0.94	1.08	1.57	1.39	1.24
EPS Growth	72.61%	-13.05%	-31.18%	12.69%	12.33%	21.68%
Free Cash Flow	165.86	364.53	71.14	29.24	5.93	143.91
Free Cash Flow Per Share	0.72	1.58	0.31	0.13	0.03	0.70
Dividend Per Share	0.096	-	0.295	0.495	-	-
Dividend Growth	-73.35%	-	-40.40%	-	-	-
Gross Margin	40.23%	37.55%	35.72%	47.47%	48.74%	47.04%
Operating Margin	23.64%	19.31%	32.66%	32.14%	33.42%	32.93%
Profit Margin	18.35%	12.38%	18.20%	25.83%	23.80%	21.52%
Free Cash Flow Margin	9.38%	20.78%	5.18%	2.08%	0.43%	12.18%
EBITDA	458.07	378.91	478.15	469.62	474.85	404.94
EBITDA Margin	25.89%	21.60%	34.83%	33.38%	34.75%	34.26%
D&A For EBITDA	39.79	40.11	29.87	17.43	18.22	15.81
EBIT	418.28	338.8	448.28	452.19	456.62	389.13
EBIT Margin	23.64%	19.31%	32.66%	32.14%	33.42%	32.93%
Effective Tax Rate	27.42%	26.85%	25.95%	23.06%	32.87%	28.08%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.